Pathway network of pyroptosis and its potential inhibitors in acute kidney injury.
Pharmacol Res
; 175: 106033, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34915124
Palabras clave
Ac-FLTD-CMK (PubChem CID: 155906572); Acute kidney injury; Bay 117082 (PubChem CID: 5353431); C16 (PubChem CID: 6490494); CY-09 (PubChem CID: 75070350); Dimethyl fumarate (PubChem CID: 637568); Disulfiram (PubChem CID: 3117); Glycyrrhizin (PubChem CID: 14982); JC124 (PubChem CID: 117715670); Lenalidomide (PubChem CID: 216326); MCC950 (PubChem CID: 9910393); MNS (PubChem CID: 672296); Mdivi-1 (PubChem CID: 3825829); NLRP3 inflammasome; Necrosulfonamide (PubChem CID: 1566236); OLT1177 (PubChem CID: 12714644); Oridonin (PubChem CID: 5321010); Parthenolide (PubChem CID: 7251185); Pyroptosis; Pyroptosis inhibitor; RRx-001 (PubChem CID: 15950826); Salvianolic acid B (PubChem CID: 6451084); Signaling pathway; Tranilast (PubChem CID: 5282230); VX-740 (PubChem CID: 153270); VX-765 (PubChem CID: 11398092); Vitamin D (PubChem CID: 5280795); z-VAD-fmk (PubChem CID: 8714607)
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Lesión Renal Aguda
/
Piroptosis
Límite:
Animals
/
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article